Survival, Prognosis, and Clinical Feature of Refractory Myasthenia Gravis: a 15-year Nationwide Cohort Study
CONCLUSION: Despite the severe prognosis of rMG, the strategies for pharmacotherapeutic regimens were similar in those two groups, suggesting that intensive monitoring and introduction of timely treatment options in the early phase of MG are required.PMID:34636500 | DOI:10.3346/jkms.2021.36.e242
Source: J Korean Med Sci - Category: General Medicine Authors: Sohyun Jeong Yunha Noh In-Sun Oh Yoon-Ho Hong Ju-Young Shin Source Type: research
More News: Autoimmune Disease | Databases & Libraries | Emergency Medicine | General Medicine | Myasthenia Gravis | Pneumonia | Study | Women